Draft one-pagers for the Grove follow-up package, built on the standard Adaptyv slide chassis from real data. For internal review before anything goes to Grove.
Draft, not sent. Pricing on page 1 is Julian's verbal call quote, marked draft and pending sign-off. The benchmark uses public Jain et al. 2017 antibody values; the correlation pages use anonymized platform data on public drugs and targets (org names and experiment codes scrubbed). None of these are in a deck manifest yet, so nothing ships until approved.
01Developability assays and pricingthe panel, workflow, and cost split
Click to open full resolution in a new tab.
02Developability benchmarkapproved antibodies, each liability caught
